Nick Klenske

By building the market’s first commercial lab-scale soft X-ray microscope, the EU-funded SMILE project has helped increase researcher productivity.

Using a qualitative approach, two researchers uncover the many factors that contribute to an HIV-positive gay man’s decision to migrate to and remain in a certain city or country.

New research shows how QSOX1 inhibitory antibodies can slow tumour growth and metastasis, potentially opening the door to an anti-metastatic cancer drug.

New research advances our understanding of what causes splenic marginal zone lymphoma and chronic lymphocytic leukaemia.

New research shows how the nervous and immune systems ‘talk’ to each other to promote health and fight disease.

The discovery of a cell type that essentially hides from conventional therapy could open the door to new ways of treating cancer.

By unraveling the epigenomic landscape of childhood leukemia, researchers aim to identify a less toxic way of treating this aggressive form of cancer.

New research demonstrates how biohybrid and biodegradable nanovaccines can provide effective, personalised cancer treatment.

While developing a non-steroid cream for treating eczema, a pharmaceutical company discovered that the compound can also be used to treat respiratory infections.

For enthusiasts, the first snowfall means the start of the winter sports season. But for radiologists, the winter months mean an inevitable increase in brain, spine, and head and neck injuries.

Although soft tissue masses (STMs) account for approximately 1% of malignant lesions, small lesions are often assumed to be benign. Current guidelines include resection biopsy for lesions with a diameter of less than 3 cm., which creates the risk of failing to achieve tumor-free margins.

Understanding the epidemiology of lower back pain could improve the process for selecting patients for treatment and further management.

While smoking is a known cause of lung cancer, it also causes cardiovascular disease. In fact, according to data from the National Lung Screening Trial, atherosclerotic cardiovascular disease (ASCVD), not lung cancer, is the leading cause of death for individuals receiving lung cancer screening (LCS).

Nobody wants to open their email to find a message from their CIO written in all caps – especially one that concludes with the unnecessary clarification, "YES I AM YELLING AT YOU!"

Growing up in India, Bhavya Rehani, MD, saw firsthand the effect that poor access to health care can have. “When my grandfather had a stroke, he didn’t have access to the doctors and therapists he needed,” she remembers. “This experience opened my eyes to the pain and suffering that can arise due to a lack of access to health care.”